Shaperon

Shaperon ROE

The Return on Equity (ROE) of Shaperon (378800.KQ) as of Oct 16, 2026 is -62.75 %. In the previous year, Return on Equity (ROE) was -93.14 % — a change of -32.63% (higher).

ROE

-62.75 %

YoY

-32.63%

Last updated:

In 2025, Shaperon's return on equity (ROE) was -62.75 %, a -32.63% increase from the -93.14 % ROE in the previous year.

The Shaperon ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
48.93 KRW
Jan 1, 2020
50.09 KRW
Jan 1, 2021
-97.68 KRW
Jan 1, 2022
-36.45 KRW
Jan 1, 2023
-65.29 KRW
Jan 1, 2024
-93.14 KRW
Jan 1, 2025
-62.75 KRW
The Shaperon ROE history
YEARROEYoY
-62.75 %-32.63%
-93.14 %+42.65%
-65.29 %+79.13%
-36.45 %-62.68%
-97.68 %-295.02%
50.09 %+2.36%
48.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shaperon Stock analysis

What does Shaperon do? Shaperon Inc is a biotechnology company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the development of pharmaceutical products targeting conditions such as atopic dermatitis, septicemia, and Alzheimer's disease. Shaperon Inc. has a workforce of 40 full-time employees. The company completed its initial public offering (IPO) on October 19, 2022, and is listed under the ticker symbol 378800.KQ with ISIN KR7378800007. Its website is http://shaperon.com/. Shaperon Inc. is engaged in research, development, manufacturing, and commercialization of therapeutic solutions for pneumonia, Alzheimer's disease, and atopic conditions, among other medicines. The company's headquarters are located in Seoul, South Korea. Shaperon Inc. operates as a publicly traded entity following its IPO in 2022, with a focus on advancing treatments for complex medical conditions through biotechnology innovation. Shaperon is one of the most popular companies on Eulerpool.

ROE Details

Decoding Shaperon's Return on Equity (ROE)

Shaperon's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Shaperon's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Shaperon's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Shaperon’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Shaperon stock

Return on Equity (ROE) of Shaperon is -62.75 % in 2025.

Return on Equity (ROE) of Shaperon changed from -93.14 % to -62.75 %, representing a -32.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Shaperon since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Shaperon with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shaperon

All Key Metrics — Shaperon